Resultats de la cerca - Jocelyn Sendecki

  • Mostrar 1 - 7 resultats de 7
Refinar resultats
  1. 1
    An Intervention for Sensory Difficulties in Children with Autism: A Randomized Trial

    An Intervention for Sensory Difficulties in Children with Autism: A Randomized Trial per Roseann C. Schaaf, Teal Benevides, Zoe Mailloux, Patricia Faller, Joanne Hunt, Elke van Hooydonk, R. Austin Freeman, Benjamin E. Leiby, Jocelyn Sendecki, Donna Kelly

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis

    Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis per Smruthi Vijayaraghavan, Lorraine Lipfert, Kristen Chevalier, Barbara S. Bushey, Benjamin J. Henley, Ryan Lenhart, Jocelyn Sendecki, Marilda Beqiri, Hillary J. Millar, Kathryn Packman, Matthew V. Lorenzi, Sylvie Laquerre, Sheri L. Moores

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia

    A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia per Priyanka Nair-Gupta, Michael Diem, Dara Reeves, Weirong Wang, Robert Schulingkamp, Katrin Sproesser, Bethany Mattson, Bradley Heidrich, Mark Mendonça, Jocelin Joseph, Jocelyn Sendecki, Brad Foulk, Gerald Chu, Damien Fink, Qun Jiao, Sheng‐Jiun Wu, Kathryn Packman, Yusri Elsayed, Ricardo M. Attar, François Gaudet

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis

    Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis per Kilian Eyerich, Khusru Asadullah, Andreas Pinter, Peter Weisenseel, Kristian Reich, C. Paul, Robert Sabat, Kerstin Wolk, Stefanie Eyerich, Felix Lauffer, Julianty Angsana, Friedemann Taut, Kristen Kohler, Yanqing Chen, Jocelyn Sendecki, Monica Leung, Sven Wegner, Yvonne Personke, Mario Gomez, Nenja Krüger, Sarah Tabori, Knut Schäkel

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  5. 5
    Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab

    Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab per Kristine A. Frerichs, Marloes E.C. Broekmans, Jhon A. Marin Soto, Berris van Kessel, Martijn W. Heymans, Lisa C. Holthof, Christie P.M. Verkleij, Rengasamy Boominathan, Bhavesh Vaidya, Jocelyn Sendecki, Amy Axel, François Gaudet, Kodandaram Pillarisetti, Sonja Zweegman, Homer Adams, Tuna Mutis, Niels W.C.J. van de Donk

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

    Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma per Christie P.M. Verkleij, Marloes E.C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth J. Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy P. Wong, Raluca Verona, Pieter Sonneveld, Sonja Zweegman, Homer Adams, Tuna Mutis, Niels W.C.J. van de Donk

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    A functional genomics predictive network model identifies regulators of inflammatory bowel disease

    A functional genomics predictive network model identifies regulators of inflammatory bowel disease per Lauren Peters, Jacqueline Perrigoue, Arthur Mortha, Alina C. Iuga, Won‐Min Song, Eric M. Neiman, Sean R. Llewellyn, Antonio Di Narzo, Brian Kidd, Shannon Telesco, Yongzhong Zhao, Aleksandar Stojmirović, Jocelyn Sendecki, Khader Shameer, Riccardo Miotto, Bojan Losic, Hardik Shah, Eunjee Lee, Minghui Wang, Jeremiah J. Faith, Andrew Kasarskis, Carrie Brodmerkel, Mark Curran, Anuk Das, Joshua R. Friedman, Yoshinori Fukui, Mary Beth Humphrey, Brian M. Iritani, Nicholas E. S. Sibinga, Teresa K. Tarrant, Carmen Argmann, Ke Hao, Panos Roussos, Jun Zhu, Bin Zhang, Radu Dobrin, Lloyd Mayer, Eric E. Schadt

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: